Nicolas Moitessier
@nic_moitessier
Followers
416
Following
1K
Media
3
Statuses
358
Professor at @McGillU. Medicinal and Computational Chemistry. husband and proud father of 3. Hockey (🇨🇦) and football/soccer (🇫🇷) fan
Brossard, Québec, Canada
Joined December 2016
RT @mmckeague: Exceptional week! 2nd #aptamer paper online @NAR_Open by talented Dr. @MairaRivera + Omma Ayon! We developed a *FASST* way t….
0
4
0
RT @NSERC_PROMOTE: Don’t miss our teams Lab training modules! - Molecular modelling .@nic_moitessier @NSERC_CRSNG….
0
2
0
RT @digital_rsc: Weiser, Moitessier et al. demonstrate how machine learning methods can be combined with molecular docking to improve predi….
0
3
0
RT @ChemCommun: Learn more about recent key research in this Feature Article 'Computational and biophysical methods for the discovery and o….
0
4
0
RT @BenBlaiszik: Ben Weiser and team worked to learn how well GPT3 understand SMILES strings - with applications in molecular fragmentation….
0
2
0
RT @NMX_Research: Nous recrutons ! Si vous êtes passionné par la découverte de médicaments et que vous avez une formation en biophysique, n….
0
1
0
RT @CIC_ChemInst: The Biological & Medicinal Chemistry Lectureship Award is presented to a scientist who has made a distinguished contribut….
0
3
0
RT @MolForecaster: (1/6) We are proud to announce that our co-founder and CSO, Prof. @nic_moitessier, is the 2023 winner of the @CIC_ChemIn….
0
3
0
RT @MolForecaster: [PAPER] Recent #drugdiscovery research from our CSO's lab at @mcgillu @McGillChemistry showcases hit discovery, covalent….
0
3
0
RT @ScienceofPD: New research from @jftrempe & colleagues presents a method of using isotope-labeled D3-leucine to measure protein turnover….
0
3
0
RT @MolForecaster: (1/4) Last month, our co-founder and CSO, @nic_moitessier, along with collaborators @mcgillu, published his lab's recent….
0
2
0
You want to dock covalent inhibitors or metalloenzyme inhibitors. Our docking programm FITTED is what you need!.
#Docking Ligands into Flexible and Solvated Macromolecules. 8. Forming New Bonds─Challenges and Opportunities #MolecularModeling #DrugDesign . .@AnneLabarre_PhD @JPottel @nic_moitessier .#current_issue #JCIM #Pharmaceutical_Modeling
0
2
7
Needless to say, this would have not been possible without the outstanding graduate students and post docs working tirelessly to design, synthesize and test these molecules!.
0
0
2
A great collaboration with @MittermaierLab, and CRBS .@SchmeingLab. Some more to come! Stay tuned!.
Great story on the structure-based development of #COVID19 therapeutics targeting 3CLpro, by @nic_moitessier, @MittermaierLab, and CRBS @SchmeingLab. Structures rule!.
1
0
5
RT @JPottel: Hey #compchem and #chemtwitter: we believe we're having a #CCCE2022 in Calgary 🇨🇦 in June, @nic_moitessier and I are organizin….
0
10
0
A really unique database. A must read for those developing phosphine ligands for catalysis. @gabepgomes @A_Aspuru_Guzik @Sigman_Lab @tobiasgensch.
Excited to see this collaboration with @Sigman_Lab @tobiasgensch @gabepgomes @gomes_group_cmu out in the world! This was the crown jewel of Gabe’s postdoc in the #matterlab and as we say us 7 papers into 1. @acceleration_c @chemuoft @UofTCompSci @acsJACS.
0
0
6
We start the new year with a publication on our efforts to develop SARS-CoV2 3CLpro covalent inhibitors. A major team effort which is still ongoing.
0
0
5